<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02292914</url>
  </required_header>
  <id_info>
    <org_study_id>NP433/13</org_study_id>
    <nct_id>NCT02292914</nct_id>
  </id_info>
  <brief_title>Prospective Analysis of Robot-Assisted Surgery</brief_title>
  <official_title>Prospective Analysis of Robot-Assisted Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto do Cancer do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto do Cancer do Estado de São Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The robot-assisted surgery allows three-dimensional view, detailed access of small&#xD;
      structures, depth perception and articulated movements with wide latitude. Thinking about the&#xD;
      inclusion of this branch of surgical outcome ICESP encouraged the training of their doctors&#xD;
      and other health professionals , and has three tutors in the area of robot- assisted&#xD;
      laparoscopic surgery , and various medical clinical staff , already trained , and already&#xD;
      perform the procedure in other centers . The da Vinci ® Surgical System ( only existing in&#xD;
      the World market) , consisting of one or two consoles for the surgeon and a tutor if&#xD;
      necessary was adopted. Ergonomically designed, a stand next to the patient , with four&#xD;
      interactive robotic arms , one of them , a vision system for high performance and the other&#xD;
      three for exclusive EndoWrist ® instruments . Driven by the latest robotic technology ,&#xD;
      computer programs , frictionless transmission of manual controls , movements in scale and&#xD;
      filtered made by the surgeon in the da Vinci ® System console are translated into precise&#xD;
      movements of the instruments EndoWrist ® For surgeons , the da Vinci ® System offers superior&#xD;
      3D viewing with larger surgical precision ergonomic comfort and dexterity . For hospitals ,&#xD;
      the da Vinci ® Surgical System enables clinical and economic benefits of minimally invasive&#xD;
      surgery are applied to a broader base of patients cirúrgicos.The main objective is to&#xD;
      evaluate the safety and effectiveness of robotic surgery in the surgical treatment of cancer&#xD;
      in operations below, as their specialties : Digestive , Urology , Gynecology , Head and Neck&#xD;
      and Thorax . This is a prospective study lasting 36 months , where 1120 patients with&#xD;
      surgical diseases in programming for the following operations will be studied : transthoracic&#xD;
      esophagectomy ; subtotal gastrectomy with lymphadenectomy ; partial pancreatectomy ;&#xD;
      resection of the rectum ; prostatectomy ; cystectomy ; partial nephrectomy ; hysterectomy&#xD;
      with or without pelvic and paraaortic lymphadenectomy ; resection of malignant tumors of the&#xD;
      mouth and orofaringolaringe and lung lobectomy . Patients will come from the outpatient&#xD;
      services of the Institute of Cancer of São Paulo - ICESP&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective study lasting 36 months. This project includes 10 subprojects in five&#xD;
      different specialties:&#xD;
&#xD;
      Specialty: Surgery of the Digestive System Subproject 1: trans-thoracic esophagectomy&#xD;
      Subproject 2: subtotal gastrectomy with lymphadenectomy Subproject 3: partial pancreatectomy&#xD;
      Subproject 4: resection of the rectum Specialty: Urology Surgery Subproject 5: cystectomy&#xD;
      Subproject 6: Prostatectomy Subproject 7: Partial Nephrectomy Specialty: Gynecological&#xD;
      Surgery Activity 8: Hysterectomy with or without pelvic lymphadenectomy and paraaortic&#xD;
      Specialty: Head and Neck Surgery Activity 9: resection of malignant tumors of the mouth and&#xD;
      orofaringolaringe Specialty: Thoracic Surgery Subproject 10: pulmonary lobectomies&#xD;
&#xD;
      Each subproject will have a study design, inclusion criteria, exclusion criteria and specific&#xD;
      methodologies.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 10, 2014</start_date>
  <completion_date type="Anticipated">July 10, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 10, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative Complications</measure>
    <time_frame>30 days</time_frame>
    <description>The postoperative complications will be mesured by clavien-dindo scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ICU and hospital length of stay</measure>
    <time_frame>2 days</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Surgical time</measure>
    <time_frame>1 day</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Intraoperative complications</measure>
    <time_frame>1 day</time_frame>
    <description>The intraoperative complications will be mesured by clavien-dindo scale</description>
  </other_outcome>
  <other_outcome>
    <measure>quality of life of cancer patients</measure>
    <time_frame>36 months</time_frame>
    <description>The quality of life will be measured by the EORTC QLQ-C30 questionnaire, developed to assess the quality of life of cancer patients</description>
  </other_outcome>
  <other_outcome>
    <measure>overall survival</measure>
    <time_frame>5 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Disease free survival</measure>
    <time_frame>5 years</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1120</enrollment>
  <condition>Esophageal Cancer</condition>
  <condition>Gastric Cancer</condition>
  <condition>Pancreatic Cancer</condition>
  <condition>Rectal Cancer</condition>
  <condition>Bladder Cancer</condition>
  <condition>Prostate Cancer</condition>
  <condition>Renal Cancer</condition>
  <condition>Uterus Cancer</condition>
  <condition>Head and Neck Cancer</condition>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Robot-Assisted Surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients undergoing robot assisted surgery for the treatment of cancer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients undergoing conventional surgery for the treatment of cancer</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Robot-assisted surgery</intervention_name>
    <description>Robot-assisted esophagectomy; Robot-assisted subtotal gastrectomy; Robot-assisted pancreatectomy;Robot-assisted rectal resection; Robot-assisted radical cistectomy;Robot-assisted prostatectomy;Robot-assisted Partial Nephrectomy; Robot-assisted hysterectomy;Robot-assisted Resection of malignant tumors of the mouth and orofaringolaringe; Robot-assisted lung lobectomy</description>
    <arm_group_label>Robot-Assisted Surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional Surgery</intervention_name>
    <description>Thoracoscopic Esophagectomy; Open rectal resection and rectal laparoscopy resection; Open radical cistectomy; Open prostatectomy; Open Partial Nephrectomy; Laparoscopic hysterectomy; Laparoscopic lung lobectomy</description>
    <arm_group_label>Conventional Surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients eligible for robotic-assisted surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant patients&#xD;
&#xD;
          -  Patients with decompensated systemic diseases&#xD;
&#xD;
          -  Patients who were unfit for general anesthesia&#xD;
&#xD;
          -  Patients without an indication for surgical treatment of cancer&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ivan Cecconello, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculdade de Medicina da USP</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ulysses Ribeiro-Junior, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculdade de Medicina da USP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ivan Cecconello, MD</last_name>
    <email>icecconello@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ulysses Ribeiro-Junior, MD</last_name>
    <email>ulyssesribeiro@terra.com.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Instituto do Câncer de São Paulo - ICESP</name>
      <address>
        <city>São Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ivan Cecconello, MD</last_name>
      <email>icecconello@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Silvia Kobayashi, MD</last_name>
      <email>silvia@kobayashi@icesp.org.br</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>September 3, 2014</study_first_submitted>
  <study_first_submitted_qc>November 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2014</study_first_posted>
  <last_update_submitted>August 6, 2019</last_update_submitted>
  <last_update_submitted_qc>August 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Neoplasms</mesh_term>
    <mesh_term>Uterine Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

